VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	06:20	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/31	05:48	PR Newswire (US)	Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/30	03:17	PR Newswire (US)	Vanda Pharmaceuticals Announces Presentations at SLEEP 2024	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/25	05:49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/25	05:46	PR Newswire (US)	Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/25	05:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/25	05:31	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/22	05:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/22	05:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/22	05:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/22	05:34	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/21	06:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/15	21:45	PR Newswire (US)	Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/14	05:15	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/10	06:15	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/09	20:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/09	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/09	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/08	05:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/08	00:16	PR Newswire (US)	Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/05/01	05:30	PR Newswire (US)	Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/04/25	21:05	GlobeNewswire Inc.	Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/04/23	08:13	PR Newswire (US)	Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/04/17	23:21	PR Newswire (US)	Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/04/17	22:02	PR Newswire (US)	Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/04/03	23:25	AllPennyStocks.com	Biotech Catches Major Premarket Bid Following FDA Approval	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/04/03	07:10	PR Newswire (US)	Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/03/08	06:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/03/07	06:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2024/03/07	06:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc